1. The Octopus Study
- Author
-
Johannes T. A. Knape, Diederick E. Grobbee, Erik Buskens, Etienne O. Robles de Medina, Hendrik M. Nathoe, Diederik van Dijk, Peter de Jaegere, Jan C. Diephuis, Johan J. Bredée, Frank D. Eefting, Cornelius Borst, Arno P. Nierich, and Erik W.L. Jansen
- Subjects
Pharmacology ,medicine.medical_specialty ,business.industry ,Cost effectiveness ,medicine.medical_treatment ,Stent ,medicine.disease ,Surgery ,law.invention ,Clinical trial ,Angina ,surgical procedures, operative ,Randomized controlled trial ,Bypass surgery ,law ,Internal medicine ,Angioplasty ,medicine ,Clinical endpoint ,Cardiology ,cardiovascular diseases ,business - Abstract
The Octopus Study consists of two multicenter randomized clinical trials in which coronary artery bypass grafting on the beating heart (off-pump CABG) using the Utrecht Octopus Method is compared to intracoronary stent implantation and conventional CABG. The primary endpoint in the comparison of off-pump CABG versus stent implantation (OctoStent Trial) is medical effectiveness (i.e., absence of reintervention and major adverse cardiac and cerebrovascular events at 1 year after treatment). The primary endpoint in the comparison of off-pump CABG versus conventional CABG (OctoPump Trial) is cerebral safety (i.e., absence of cognitive deficits and cerebrovascular events at 3 months after treatment). Secondary endpoints in both trials include presence and severity of angina, quality of life, exercise capacity, and cost-effectiveness. A total of 560 patients will be enrolled. A random sample of 210 patients will undergo repeat angiography at 1 year to assess angiographic restenosis rate and graft patency. Including 1-year follow-up, the study will last for 3 years. Control Clin Trials 2000;21:595-609
- Published
- 2000
- Full Text
- View/download PDF